Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma
Conclusion:The restoration of visual function in glaucoma patients by the RGC replacement therapies requires appropriate protocols and biotechnology methods. Tissue-engineered scaffolds, the generation of retinal organoids, and gene therapy may help to overcome some of the challenges in the generation of clinically safe RGCs.
Source: Tissue Engineering and Regenerative Medicine - Category: Biotechnology Source Type: research
More News: Biotechnology | Blindness | Brain | Disability | Eyes | Ganglions | Gene Therapy | Genetics | Glaucoma | Neurology | Opthalmology | Study | Transplants | Vitamin A